par De Buck, René
Référence Current medical research and opinion, 1, 5, page (291-295)
Publication Publié, 1973
Article révisé par les pairs
Résumé : A double-blind crossover study was designed to compare the anxiolytic properties of the benzodiazepines, lorazepam and diazepam, and to evaluate the principal side-effects prior to lorazepam's wider use in patients. Thirty patients with psychic or somatic symptoms of anxiety were given one active drug for a month, a placebo for 15 days and the other active drug for one month. Both lorazepam 1.25 mg. t.d.s., and diazepam 5 mg. t.d.s., alleviated anxiety to the same extent and gave a similar incidence of side-effects. Further use of lorazepam in a large number of patients has shown that most benefit from 1 mg. t.d.s. This dose could be increased progressively to 2.5 mg. t.d.s. It is suggested that lorazepam deserves particular attention since it is the most potent member of the benzodiazepine anxiolytics in clinical use. © 1973 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.